InsidersTradesSigma
申报总数
公司
▲ 买入（0 笔）
▼ 卖出（0 笔）
内部人交易记录
董事已披露买入
0
已披露卖出
0
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
信号历史
无可用的信号评分。
Browse the detailed record of transactions filed by Horning Sandra, 董事. Director active across 4 companies, notably EQRx, Inc.. In total, 12 filings have been logged. History available since 28 April 2022. The latest transaction was filed on 26 June 2025 (Attribution). Regulator: SEC (Form 4). The full history is accessible without signup.
Companies and markets linked to Horning Sandra
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报12 总计
3,142 股0Common StockSEC:0001610717-25-000273:0
1,516 股0Common StockSEC:0001127602-25-013774:0
979 股Common StockSEC:0001127602-25-012934:0
2,945 股0Common StockSEC:0001610717-24-000373:0
4,800 股0Common StockSEC:0001610717-24-000362:0
52,291 股Common StockSEC:0001610717-23-000356:0
470,250 股Common StockSEC:0000899243-23-020303:0
1,887 股0Common StockSEC:0001127602-23-014558:0
670 股Common StockSEC:0001127602-23-013922:0
1,112 股Common StockSEC:0001127602-22-013127:0
703 股0Common StockSEC:0001127602-22-012854:0
470,250 股Common StockSEC:0000899243-21-049126:0
12 条申报中的 12 条
About Horning Sandra
Horning Sandra is Administrateur and has 12 filings in total. In the recent sample of 12 filings, the most common transaction nature is Attribution, with buy and sell amounts shown as EUR 0. The filings covered run from 2021-12-21 to 2025-06-30 and concern Revolution Medicines, Inc., Gilead Sciences, INC., Moderna, Inc. and EQRx, Inc.
